PostHeaderIcon RSS News

News from across the web.

Dozens of developing countries exaggerated figures on how many children were vaccinated against deadly diseases, which allowed them to get more money from U.N.-sponsored programs, a new study said Friday.

 

Some women with small breast tumors may have a greater risk of the cancer recurring after treatment than has been believed, and might benefit from taking the drug Herceptin, a new study suggests.

 

Researchers continue to test the mettle of breakthrough breast cancer drugs, three decades after tamoxifen changed the medical landscape by drastically reducing the risk of recurrences in women with estrogen ...

 

Scientists in the clinic and the laboratory continue to work to drive breast cancer mortality rates down with breakthrough drugs.

 

A new study at Washington University School of Medicine in St. Louis has shown that estrogen therapy can shrink tumors in some women with metastatic breast cancer.

 

Main Category: Breast Cancer Also Included In: Cancer / Oncology Article Date: 11 Dec 2008 - 7:00 PST Abraxis BioScience, Inc.

 

New research suggests that the osteoporosis drug Zometa may also help fight breast cancer.

 

Combining GlaxoSmithKline's Tykerb drug with Novartis's Femara can delay significantly the progression of breast cancer in some women, researchers said on Thursday.

 

Women who were given the drug, Zometa, as part of their initial treatment had greater tumour shrinkage and were less likely to need radical surgery, according to a preliminary study reported on Thursday at a ...

 
<< Start < Prev 61 62 63 64 65 66 67 68 69 70 Next > End >>

Page 61 of 70
Dresser After Dark
Please update your Flash Player to view content.